1. Waduthantri S, Yong SS, Tan CH et al. Cost of dry eye treatment in an Asian clinic
setting. PLoS One. 2012;7:e37711. doi:10.1371/journal.pone.0037711.
2. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on
vision related quality of life. Am J Ophthalmol. 2007;143:409–415. doi:10.1016/j.ajo.2006.11.060.
3. Nelson JD, Shimazaki J, Benitez-del-Castillo JM et al. The international workshop
on meibomian gland dysfunction: report of the definition and classification subcommittee.
Invest Ophthalmol Vis Sci. 2011;52:1930–1937. doi:10.1167/iovs.10-6997b.
4. Rabensteiner DF, Aminfar H, Boldin I, Schwantzer G, Horwath-Winter J. The prevalence
of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian
dry eye clinic population. Acta Ophthalmol. 2018. doi:10.1111/aos.13732.
5. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description,
diagnosis,classification, and grading. Ocul Surf. 2003;1:107–126.
6. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol.
2009;3:405–412.
7. Goto E, Monden Y, Takano Y et al.Treatment of non-inflamed obstructive meibomian
gland dysfunction by an infrared warm compression device. Br J Ophthalmol. 2002;86:1403–1407.
8. Ma X, Lu Y. Efficacy of Intraductal Meibomian Gland Probing on Tear Function in
Patients With Obstructive Meibomian Gland Dysfunction. Cornea. 2016;35:725–730. doi:10.1097/ico.0000000000000777.
9. Arita R, Morishige N, Koh S, Shirakawa R, Kawashima M, Sakimoto T, et al. Increased
Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter
Cross-sectional Study. Ophthalmology. 2015;122(5):925-933. doi:10.1016/j.ophtha.2014.12.018.
10. Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed
light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol. 2016;51:249–253.
doi:10.1016/j.jcjo.2016.01.005.
11. Jiang X, Lv H, Song H et al. Evaluation of the Safety and Effectiveness of Intense
Pulsed Light in the Treatment of Meibomian Gland Dysfunction. J Ophthalmol. 2016;2016:1910694.
doi:10.1155/2016/1910694.
12. Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive
meibomian gland dysfunction. Cornea. 2010;29:1145–1152. doi:10.1097/ICO.0b013e3181d836f3.
13. Sik Sarman Z, Cucen B, Yuksel N, Cengiz A, Caglar Y. Effectiveness of Intraductal
Meibomian Gland Probing for Obstructive Meibomian Gland Dysfunction. Cornea. 2016;35:721–724.
doi:10.1097/ico.0000000000000820.
14. Nakayama N, Kawashima M, Kaido M, Arita R, Tsubota K. Analysis of Meibum Before
and After Intraductal Meibomian Gland Probing in Eyes With Obstructive Meibomian Gland
Dysfunction. Cornea. 2015;34:1206–1208. doi:10.1097/ico.0000000000000558.
15. Asiedu K, Kyei S, Mensah SN, Ocansey S, Abu LS, Kyere EA. Ocular Surface Disease
Index (OSDI) Versus the Standard Patient Evaluation of Eye Dryness (SPEED): A Study
of a Nonclinical Sample. Cornea. 2016;35:175–180. doi:10.1097/ico.0000000000000712.
16. Song X, Zhao P, Wang G, Zhao X. The effects of estrogen and androgen on tear secretion
and matrix metalloproteinase-2 expression in lacrimal glands of ovariectomized rats.
Invest Ophthalmol Vis Sci. 2014;55(2):745-51. doi:10.1167/iovs.12-10457.
17. Lee H, Kim M, Park SY, Kim EK, Seo KY, Kim TI. Mechanical meibomian gland squeezing
combined with eyelid scrubs and warm compresses for the treatment of meibomian gland
dysfunction. Clinical & experimental optometry. 2017;100(6):598-602. doi:10.1111/cxo.12532.
18. Greiner JV. Long-Term (3 Year) Effects of a Single Thermal Pulsation System Treatment
on Meibomian Gland Function and Dry Eye Symptoms. Eye & contact lens. 2016;42(2):99-107.
doi:10.1097/icl.0000000000000166.
19. Jin X, Lin Z, Liu Y, Lin L, Zhu B. Hormone replacement therapy benefits meibomian
gland dysfunction in perimenopausal women. Medicine (Baltimore). 2016;95(31):e4268..
doi:10.1097/MD.0000000000004268.
20. Arita R, Mizoguchi T, Fukuoka S, Morishige N. Multicenter Study of Intense Pulsed
Light Therapy for Patients With Refractory Meibomian Gland Dysfunction. Cornea. 2018.
doi:10.1097/ico.0000000000001687.
21. Syed ZA, Sutula FC. Dynamic Intraductal Meibomian Probing: A Modified Approach
to the Treatment of Obstructive Meibomian Gland Dysfunction. Ophthal Plast Reconstr
Surg. 2017;33:307–309. doi:10.1097/IOP.0000000000000876.
22. Maskin SL, Testa WR. Growth of meibomian gland tissue after intraductal meibomian
gland probing in patients with obstructive meibomian gland dysfunction. Br J Ophthalmol.
2018;102:59–68. doi:10.1136/bjophthalmol-2016-310097.
23. Ashraf Z, Pasha U, Greenstone V, Akbar J, Apenbrinck E, Foulks GN. Quantification
of human sebum on skin and human meibum on the eye lid margin using Sebutape(R), spectroscopy
and chemical analysis. Curr Eye Res. 2011;36:553–562. doi:10.3109/02713683.2011.574331.
24. Lee H, Chung B, Kim KS, Seo KY, Choi BJ, Kim TI. Effects of topical loteprednol
etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian
gland dysfunction: randomized clinical trial. Am J Ophthalmol. 2014;158:1172–1183.e1.
doi:10.1016/j.ajo.2014.08.015.
25. Liu S, Richards SM, Lo K, Hatton M, Fay A. Sullivan DA. Changes in gene expression
in human meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2727–2740.
doi:10.1167/iovs.10-6482.
26. Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease
due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg.
2015;33:41–46. doi:10.1089/pho.2014.3819.
27. Dell SJ, Gaster RN, Barbarino SC, Cunningham DN. Prospective evaluation of intense
pulsed light and meibomian gland expression efficacy on relieving signs and symptoms
of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017;11:817–827.
doi:10.2147/opth.s130706.
28. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading
of lid changes. Eye. 1991;5 ( Pt 4):395–411. doi:10.1038/eye.1991.65.
29. Geerling G, Tauber J, Baudouin C et al. The international workshop on meibomian
gland dysfunction: report of the subcommittee on management and treatment of meibomian
gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52:2050–2064. doi:10.1167/iovs.10-6997g.
30. Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr
Eye Res. 2003;26:89–94.
31. Arita R, Morishige N, Shirakawa R, Sato Y, Amano S. Effects of Eyelid Warming
Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland
Dysfunction. Ocul Surf. 2015;13:321–330. doi:10.1016/j.jtos.2015.04.005.